Search Within
Document Type
872-85-5
Applied Filters:
Keyword:'872-85-5'
Showing 1-22 of 22 results for "872-85-5" within Technical Documents
QUALITY CONTROL RANGES - Milliplex Mouse CD8%26#43; T Cell Magnetic Bead Panel
Cytokine QC Level Expected Range Units
CD137 Control 1 52 – 109 pg/mL IL-5 Control 1 41 – 85 pg/mL
Control 2 420 – 872 pg/mL Control 2 349 – 726 pg/mL
Data Sheet - 88474
References:
1. Rappaport F. and Henigh E., 1952, J. Clin. Path., 5:361.
2. March S.B., and Ratnam S. (l986), J. Clin. Microbiol. 23, 869-872.
3. Karmali M.A., Petric M., Lim C., et al, 1985, J. infect.
Data Sheet - 83339
References:
1. Rappaport F. and Henigh E., 1952, J. Clin. Path., 5:361.
2. March S.B., and Ratnam S. (l986), J. Clin. Microbiol. 23, 869-872.
3. Karmali M.A., Petric M., Lim C., et al, 1985, J. infect.
Data Sheet - SRE0012
Human Genetics, 85 (1), 39-
40 (1990)
4. Schaefer EJ, Santos RD, Asztalos BF. Marked HDL
deficiency and premature coronary heart disease.
Curr Opin Lipidol. 21(4), 289-97 (2010)
5. Benson MD., Ostertag
RABBIT ANTI-CXCR4 (EXTRACELLULAR LOOP)
-730.
2. Feng, Y et al. (1996) Science. 272:872-877.
3. Berson, JF et al. (1996) J Virol. 70:6288-6295.
4. Doranz, BJ et al. (1996) Cell. 85:1149-1158.
5. Endres, MJ et al. (1996) Cell. 87:745-756.
Data Sheet - 88902
References:
1. Rappaport F. and Henigh E., 1952, J. Clin. Path., 5, 361.
2. March S.B., and Ratnam S. (l986), J. Clin. Microbiol. 23, 869-872.
3. Karmali M.A., Petric M., Lim C., et al, 1985, J. infect.
Product Information Sheet - F9015
Böhlen, P. et al., Arch. Biochem. Biophys.,
155(1), 213-220 (1973).
5. Udenfriend, S. et al., Science, 178(4063),
871-872 (1972).
6. Sogawa, K., and Takahashi, K., J. Biochem.,
83(6), 1783
CellASIC®ONIX live cell imaging platform for neural stem cell microenvironment control
stem cells. PLoS One 2009;
5(1):e8575
9. Takahashi K et al. Induction of pluripotent stem cells
from adult human fibroblasts by defined factors. Cell 2007;
131(5):861–872
10. Storch A et al. Long-term
Measurement of cardiovascular disease biomarkers in human clinical samples
607.0† 280.5
(153.0, 784.0) (898.5, 1155.0) (281.5, 827.8) (224.5, 305.5)
D-Dimer 1486.0† 230 872 1055.5
(1062.0, 1562.0) (188.0, 376.0) (217.0, 1094.0) (849.3, 1068.8)
GDF-15 2.3* 0.7 3.3† 1.4
Protocol: Rat/Mouse Fibroblast Growth Factor-21 (FGF-21)
Sample No. Mean FGF-21
Levels (pg/mL)
Intra-Assay
% CV
1 302 9.1
2 872 5.8
3 1495 6.2
4 2782 3.2
5 7766 3.6
6 8813 2.7
Protocol- EZRMFGF21-26K
Variation
Mean FGF-21
Levels (pg/mL) Intra-Assay %CV
1 302 9.1
2 872 5.8
3 1495 6.2
4 2782 3.2
5 7766 3.6
Empower your Lab
1-Methyl-2-pyrrolidone for analysis
EMPARTA® ACS 872-50-4 ≥ 99.0 % ≤ 0.05 % 4 l Glass bottle 1.07063.4000
1-Methyl-2-pyrrolidone EMPLURA® 872-50-4 ≥ 99.5 % ≤ 0.1 %
1 l HDPE bottle 8.06072.1000
Ionic Liquids Product Brochure
- 50°C
490202 for synthesis PMIM I
CAS-No.: 119171-18-5
M: 252.10 g/mol
mp: - 75°C
490203 for synthesis MMPL I
CAS-No.: 872-44-6
M: 227.09 g/mol
mp: 203°C
490204 for synthesis
White Paper: Improving Solubility
and that of Ordinary Sulfathiazole in Man. Chemical &
pharmaceutical bulletin, 1961. 9(11): p. 866-872.
2. Goldberg, A.H., M. Gibaldi, and J.L. Kanig, Increasing dissolution
rates and gastrointestinal
COD Comparison Table 2017
accuracy as a recovery interval from R - 2sr to R + 2sr.
For example, if R = 95%, and sr = 5%, the accuracy is
85 % to 105 %.
Quality control sample (QCS)–It
Inorganics & Solvents for classical analysis
Reag. Ph Eur 56-81-5 ≥ 99.5% ≤ 0.5%
2.5 L HDPE bottle 1.04057.2511
10 L PE canister 1.04057.9011
25 L PE canister 1.04057.9026
H
n-Heptane about 85% EMPLURA® 142-82-5 ≥ 85.0% ≤ 0.005%
Halal Certificate
W313718 A36534 HC-24SIYB17
85. 2,6-DIMETHOXYPHENOL, NATURAL, =96%, FG W313726 A69900 HC-24SIF242
86. 2,6-DIMETHYL-5-HEPTENAL FCC W238902 B14462 HC-24SIZV69
87. 2,6-DIMETHYL-5-HEPTENAL, NATURAL MIXTURE
Halal Certificate
W313718 A36534 HC-22SIXU15
85. 2,6-DIMETHOXYPHENOL, NATURAL, =96%, FG W313726 A69900 HC-22SI2L40
86. 2,6-DIMETHYL-5-HEPTENAL FCC W238902 B14462 HC-22SIYS67
87. 2,6-DIMETHYL-5-HEPTENAL, NATURAL MIXTURE
Material Matters Volume 15 number 2 Batteries & Solar Cells
electrode.32 B) The use of multiple cations and a PTAA hole contact shows losses
around 5% in 500hrs of MPP tracking at 85 °C, in a mesoporous device.33 C) Maximum power output in real working conditions shows
Cytoskeletal Signaling Antibodies, Reagents and Kits
B H M R Rb WB Pur Rb IgG 200 µg 06-870
anti-phospho-PKCβ I (Thr642) H WB APur Rb IgG 100 µL 07-872
anti-phospho-PKCβ II (Thr641) H WB APur Rb IgG 100 µL 07-873
anti-phospho-PKCβ I &
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
H M R WB antiserum Rb IgG 200 µL 07-264
Anti-phospho-PKCβ I (Thr642) H WB APur Rb IgG 100 µL 07-872
Anti-phospho-PKCβ II (Thr641) H WB APur Rb IgG 100 µL 07-873
Anti-phospho-PKCβ I&II (Thr500)
XP725 Worksheet for Lot Number 071M4826
M9942
872 5 3 1 8 MAP2 M9942
873 5 3 2 1 MBD1 M6569
874 5 3 2 2 MBD1 M6569
875 5 3 2 3 MBD2a M7568
876 5 3 2 4 MBD2a M7568
877 5 3 2 5 MBD2ab M7318
878 5 3 2